Skip to content

Prospective Cohort Study of Synovial Biomarkers in the Diagnosis and Prediction of Periprosthetic Joint Infection

Prospective Cohort Study of Synovial Biomarkers in the Diagnosis and Prediction of Periprosthetic Joint Infection

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06467734
Acronym
Yes
Enrollment
200
Registered
2024-06-21
Start date
2024-08-01
Completion date
2026-12-31
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prospective Cohort Study of Synovial Biomarkers in the Diagnosis and Prediction of Periprosthetic Joint Infection

Keywords

Prospective cohort study, synovial biomarkers, diagnosis, prediction, periprosthetic joint infection

Brief summary

Prosthetic Joint Infection (PJI) is one of the severe complications following arthroplasty. With the global aging population, the number of patients undergoing primary joint replacement surgeries is increasing, leading to a rise in PJI cases. Although the incidence of PJI is generally low, the impact on patients can be catastrophic. Once an infection occurs, it is further complicated by the rising global antibiotic resistance, imposing a significant economic burden on patients. Therefore, improving the diagnostic rate of PJI is crucial. Currently, various infection markers are used in the diagnosis of PJI. However, there is still a lack of highly sensitive and specific markers to effectively diagnose PJI, necessitating the exploration of new infection markers. This study aims to investigate novel infection markers for the diagnosis of PJI, providing evidence for its diagnosis and subsequent treatment. In this research, we will prospectively collect data from patients undergoing primary joint replacement and those developing PJI from June 2024 to December 2026. These patients will be categorized into non-infection and infection groups. By collecting and analyzing general patient data, surgery-related information, and infection-related indicators from preoperative joint fluid and blood samples, we aim to further evaluate the predictive value of these infection markers for PJI.

Interventions

DEVICEJoint aspiration

Joint puncture to extract joint fluid.

Sponsors

First Affiliated Hospital of Xinjiang Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age ≥18 years old, gender is not limited; 2. The experimental group met the diagnostic criteria of chronic periprosthesis infection after joint replacement according to the 2018 Musculoskeletal Infection Association; The control group was eligible for primary replacement patients who excluded periprosthesis infection. 3. Voluntary and signed informed consent.

Exclusion criteria

1. Patients with immune-related arthritis such as rheumatoid and rheumatism were excluded; 2. Radiotherapy and chemotherapy are required due to neoplastic diseases; 3. Receiving systemic glucocorticoid therapy (prednisone \> 10mg/ day or equivalent hormone medication); 4. Severe immunodeficiency diseases (such as stage 3 HIV, sickle cell anemia, splenectomy, etc.); 5. Have a history of drug abuse; 6. Use immunosuppressive drugs to treat bone marrow or other transplants; 7. Pregnant, parturient and lactating women; 8. Participating in other clinical trials; 9. Researchers consider other reasons not appropriate for clinical trial participants.

Design outcomes

Primary

MeasureTime frameDescription
Joint fluid target protein detectionOne day before surgery or one day after surgeryTo detect new target proteins by elisa test.

Secondary

MeasureTime frameDescription
X-rayOne day before surgery and two years after surgeryX-ray of surgery site.
Erythrocyte sedimentation rate (ESR)One day before sugery and two year after surgeryIt measures the rate at which red blood cells settle to the bottom of a test tube within one hour. Normal ranges: Male: 0 to 15 millimeters per hour (mm/hr) Female: 0 to 20 millimeters per hour (mm/hr)
C-reactive protein (CRP)One day before sugery and two year after surgeryC-reactive protein (CRP) is a protein produced by the liver that significantly increases in response to inflammation or infection. Normal range for CRP is less than 10 milligrams per liter (mg/L).
Synovial fluid white blood cell count (SF-WBC)One day before surgery and one day after surgerySynovial fluid white blood cell count (SF-WBC)
Synovial fluid polymorphonuclear cells (SF-PMN)One day before surgery and one day after surgeryPolymorphonuclear neutrophil percentage in synovial fluid refers to the proportion or percentage of polymorphonuclear neutrophils (PMN) present in the synovial fluid. This measurement is important in the assessment of joint health and inflammation, particularly in conditions such as arthritis and infections affecting the joints. Normal range: Less than 80%.
Alanine Aminotransferase (ALT)One day before surgery and one day after surgeryAn enzyme found in the liver that helps convert proteins into energy. Elevated levels indicate liver damage. Normal range: 10 to 40 units per liter (U/L)
American Knee Society Score (AKS score)One day before surgery, two years after surgeryAmerican Knee Society Score is used to evaluate the outcomes of knee replacement surgery. This scoring system consists of two main components: the knee score and the function score. Knee Score: This primarily assesses the condition of the knee joint itself, including pain, stability, and range of motion. The higher of the score, the better of the functional result.
The Hip Harris Score (HHS)One day before surgery, two years after surgeryThe Harris Hip Score (HHS) is a widely used clinical tool for assessing the outcomes of hip surgeries, particularly hip replacements. Developed by Dr. William Harris in 1969, it evaluates various aspects of hip function and pain to provide an overall score that reflects the patient's condition. The higher the score, the better the result is.
Aspartate Aminotransferase (AST)One day before surgery and one day after surgeryAn enzyme found in the liver and other tissues. High levels can indicate liver damage but are less specific than ALT. Normal range: 10 to 40 units per liter (U/L)
Serum CreatinineOne day before surgery and one day after surgeryMeasures the level of creatinine in the blood. Elevated levels can indicate impaired kidney function. Normal range: 62 to 115 micromoles per liter (µmol/L).
Blood Urea Nitrogen (BUN)One day before surgery and one day after surgeryMeasures the amount of nitrogen in the blood that comes from urea. Elevated BUN levels can indicate impaired kidney function. Normal range: 2.5 to 7.1 millimoles per liter (mmol/L).
Doppler lower extremity vascular color ultrasoundOne day before surgery and three day after surgeryDoppler lower extremity vascular color ultrasound to evaluate the deep vein thrombus development

Contacts

Primary ContactLong Hua, M.D.
hualong_xmu@163.com+8615099182364
Backup ContactLi Cao, M.D.
xjbone@sina.com+8613909915960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026